Histone deacetylase inhibitors repress chondrosarcoma cell proliferation

Journal of B.U.ON.

Volumn 20, Issue 1, 2015, Pages 269-274

  Zhu, Jiaxue ^a   Gu, Jianhua ^a   Ma, Jie ^a   Xu, Zhixing ^a   Tao, Hairong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chondrosarcoma; HDACIs; Proliferation; TSA; VPA

Indexed keywords

TRICHOSTATIN A; VALPROIC ACID; ANTINEOPLASTIC AGENT; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROSARCOMA; CHONDROSARCOMA CELL LINE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; S PHASE CELL CYCLE CHECKPOINT; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; BONE NEOPLASMS; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; METABOLISM; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHONDROSARCOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; G1 PHASE CELL CYCLE CHECKPOINTS; G2 PHASE CELL CYCLE CHECKPOINTS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MICE, NUDE; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR BURDEN; VALPROIC ACID; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84928695655     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Klenke FM, Abdollahi A, Bertl E et al. Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo. BMC Cancer 2007;7:49.
2. Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003): An analysis of 2890 cases from the SEER database. J Bone Joint Surg Am 2009;91:1063-1072.
3. Yuan J, Dutton CM, Scully SP. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J Orthop Res 2005;23:1467-1474.
4. Wu CM, Li TM, Tan TW, Fong YC, Tang CH. Berberine Reduces the Metastasis of Chondrosarcoma by Modulating the alpha v beta 3 Integrin and the PKC delta, c-Src, and AP-1 Signaling Pathways. Evid Based Complement Alternat Med 2013;2013:423164.
5. Newbold A, Salmon JM, Martin BP, Stanley K, Johnstone RW. The role of p21 andp27 in HDACi-mediated tumor cell death and cell cycle arrest in the Emu-myc model of B-cell lymphoma. Oncogene 2013;1476- 5594:1-9.
6. Nihal M, Ahmad N, Wood GS. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis. Cell Cycle 2014;13:632- 640.
7. Zhao Q, Wang C, Zhu J et al. RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cells: A case control study. J Exp Clin Cancer Res 2011;30:26-34.
8. Koutsounas I, Giaginis C, Theocharis S. Histone deacetylase inhibitors and pancreatic cancer: Are there any promising clinical trials? World J Gastroenterol 2013;19:1173-1181.
9. Jin G, Bausch D, Knightly T et al. Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro. Surgery 2011;150:429-435.
10. Magic Z, Supic G, Brankovic-Magic M. Towards targeted epigenetic therapy of cancer. JBUON 2009; 14 (Suppll):S79-S88.
11. Young DA, Lakey RL, Pennington CJ et al. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 2005;7:R503-R512.
12. Sakimura R, Tanaka K, Yamamoto S et al. The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells. Clin Cancer Res 2007;13:275-282.
13. Yamamoto S, Tanaka K, Sakimura R et al. Suberoy- lanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines. Anticancer Res 2008;28:1585-1591.
14. Chen YJ, Wu CL, Liu JF et al. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. Cancer Lett 2010;291:20-30.
15. Kim DW, Kim KO, Shin MJ et al. siRNA-based tar geting of antiapoptotic genes can reverse chemore- sistance in P-glycoprotein expressing chondrosarcoma cells. Mol Cancer 2009;8:28-37.
16. Chow WA. Update on chondrosarcomas. Curr Opin Oncol 2007;19:371-376.
17. Lin CY, Chang SL, Fong YC, Hsu CJ, Tang CH. Apoptosis signal-regulating kinase 1 is involved in brain-derived neurotrophic factor (BDNF)-enhanced cell motility and matrix metalloproteinase 1 expression in human chondrosarcoma cells. Int J Mol Sci 2013;14:15459-15478.
18. Wittenburg LA, Bisson L, Rose BJ, Korch C, Thamm DH. The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin. Cancer Chemother Pharmacol 2011;67:83-92.
19. Fu J, Shao CJ, Chen FR, Ng HK, Chen ZP. Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro Oncol 2010;12:328- 340.
20. Xia Q, Sung J, Chowdhury W et al. Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo. Cancer Res 2006;66:7237- 7244.
21. Salvador MA, Wicinski J, Cabaud O et al. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression. Clin Cancer Res 2013;19:6520-6531.
22. Iwahashi S, Ishibashi H, Utsunomiya T et al. Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines. J Med Invest 2011;58:106-109.
23. Tang YA, Wen WL, Chang JW et al. A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer. PLoS One 2010;5:e12417.
24. Tumber A, Collins LS, Petersen KD et al. The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo. Cancer Chemother Pharmacol 2007;60:275-283.
25. Wu ZQ, Zhang R, Chao C, Zhang JF, Zhang YQ. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell. Chin Med J (Engl) 2007;120:2112-2118.
26. Wu Z, Ma C, Shan Z, Ju Y, Zhao Q. Histone deacetylase inhibitors suppress the growth of human osteosarcoma in vitro and in vivo. JBUON 2013;18:1032-1037.
27. Sun X, Wei L, Chen Q, Terek RM. HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity. J Biol Chem 2009;284:21881-21890.
28. Yang C, Choy E, Hornicek FJ et al. Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells. Cancer Chemother Pharmacol 2011;67:439-446.
29. Yang C, Choy E, Hornicek FJ et al. Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines. Anticancer Res 2011;31:1115-1123.